Microbiologie & CCS
Comment prouvons-nous la stérilité — et maintenons-nous la contamination control strategy lorsque l’inspecteur arrive ?
ArticleBiofluorescence Monitoring In Cleanrooms: A Simple Guide
Hunting contamination used to be a blind search. Biofluorescence monitoring lights it up in real time, seconds, not days, to spot it.
CCS: What Inspectors Actually Asked For in the Last 18 Months
Contamination control strategy has become the document inspectors judge first. See the 5 questions MHRA and FDA kept asking over the last 18 months.
Gut-Skin Axis: What Happens Before Symptoms Appear
A single antibiotic course can disrupt gut bacteria for months, affecting the gut-skin axis. Discover the hidden microbiome trajectory.
Hospital-Acquired Infection Risk: Hidden Microbial Threats
Hospital-acquired infection risk is shaped by microbial balance, not just single pathogens. Explore the 99% AMR-reduction trial data.
20260813154958.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
Modern Strategies For Mycoplasma Risk Management: The Silent Contaminant In Biopharmaceutical Manufacturing
Mycoplasma is invisible to routine checks. Modern risk management combines prevention, rapid detection, and compliant response.
From Compliance to Contamination Control: How Annex 1 Is Reshaping Pharmaceutical Microbiology?
EU GMP Annex 1 made zero CFU the new Grade A standard. Here's how it's reshaping contamination control, EM programmes, and pharma microbiology.
The Sampler That Was Watching the Wrong Air
How a compliant environmental monitoring programme became a blindfold, and what every sterile facility should ask before the next contamination event.
InPharma_AcceleratingQuality%2CCompliance%2CAndManufacturingEfficiency20260812190143.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
Rapid Microbiology Methods (RMMs) In Pharma: Accelerating Quality, Compliance, And Manufacturing Efficiency
A 14-day sterility test can outlast a product's shelf life. Here's how RMMs cut detection time and stay FDA, EMA compliant.
20260813122022.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
Turbulence: The Hidden Enemy In Sterile Manufacturing
Turbulence is the hidden contamination risk in sterile manufacturing, First Air, smoke studies, isolators and Annex 1 explained.
Why Microbial Biofilms Remain One Of Healthcare’s Toughest Challenges?
Biofilms resist antibiotics, evade immune defenses, and persist on medical devices. Here's why they remain one of pharma's toughest challenges.